Malignancies During clinical trials, there was a numerical imbalance in cancers arising in the Xolair treatment group compared with the control group.
Pahaloomulised kasvajad Kliinilistes uuringutes esines kasvajate esinemissageduse arvuline erinevus Xolair- ravi grupi ja kontrollgrupi vahel.